Emerging role of carbonic anhydrase inhibitors

CT Supuran - Clinical Science, 2021 - portlandpress.com
Inhibition of carbonic anhydrase (CA, EC 4.2. 1.1) was clinically exploited for decades, as
most modern diuretics were obtained considering as lead molecule acetazolamide, the …

Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?

CB Mishra, M Tiwari, CT Supuran - Medicinal Research …, 2020 - Wiley Online Library
Abstract Carbonic anhydrases (CAs, EC 4.2. 1.1) are widely distributed metalloenzymes in
both prokaryotes and eukaryotes. They efficiently catalyze the reversible hydration of carbon …

A simple yet multifaceted 90 years old, evergreen enzyme: Carbonic anhydrase, its inhibition and activation

CT Supuran - Bioorganic & Medicinal Chemistry Letters, 2023 - Elsevier
Advances in the carbonic anhydrase (CA, EC 4.2. 1.1) research over the last three decades
are presented, with an emphasis on the deciphering of the activation mechanism, the …

Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?

V Alterio, A Di Fiore, K D'Ambrosio, CT Supuran… - Chemical …, 2012 - ACS Publications
Carbonic anhydrases (CAs, EC 4.2. 1.1) are ubiquitous metallo-enzymes, present
throughout most living organisms and encoded by five evolutionarily unrelated gene …

Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase

A Nocentini, A Angeli, F Carta, JY Winum… - Journal of Enzyme …, 2021 - Taylor & Francis
Inorganic anions inhibit the metalloenzyme carbonic anhydrase (CA, EC 4.2. 1.1) generally
by coordinating to the active site metal ion. Cyanate was reported as a non-coordinating CA …

Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease

JT Dudley, M Sirota, M Shenoy, RK Pai… - Science translational …, 2011 - science.org
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal
tract for which there are few safe and effective therapeutic options for long-term treatment …

Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors

A Maresca, C Temperini, H Vu, NB Pham… - Journal of the …, 2009 - ACS Publications
The X-ray crystal structure of the adduct between the zinc metalloenzyme carbonic
anhydrase II (CA, EC 4.2. 1.1) with the recently discovered natural product coumarin …

Antibacterial carbonic anhydrase inhibitors: an update on the recent literature

CT Supuran, C Capasso - Expert Opinion on Therapeutic Patents, 2020 - Taylor & Francis
Introduction The clinically licensed drugs used as antibiotics prevent the microbial growth
interfering with the biosynthesis of proteins, nucleic acids, microorganism wall biosynthesis …

Investigation of inhibitory properties of some hydrazone compounds on hCA I, hCA II and AChE enzymes

K Kucukoglu, HI Gul, P Taslimi, I Gulcin… - Bioorganic chemistry, 2019 - Elsevier
Recently, inhibition of carbonic anhydrase (hCA) and acetylcholinesterase (AChE) have
appeared as a promising approach for pharmacological intervention in a variety of disorders …

Anti-infective carbonic anhydrase inhibitors: a patent and literature review

C Capasso, CT Supuran - Expert opinion on therapeutic patents, 2013 - Taylor & Francis
Introduction: All microorganisms that cause diseases or illnesses to their host are defined as
pathogens. In this paper we will review the current state of the art for inhibiting parasite …